These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 21869931)

  • 1. TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S Mutations.
    Abedi-Ardekani B; Gouas D; Villar S; Sotoudeh M; Hainaut P
    Hepat Res Treat; 2011; 2011():475965. PubMed ID: 21869931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
    Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
    Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus.
    Han C; Yu T; Qin W; Liao X; Huang J; Liu Z; Yu L; Liu X; Chen Z; Yang C; Wang X; Mo S; Zhu G; Su H; Li J; Qin X; Gui Y; Mo Z; Li L; Peng T
    J Gastrointest Oncol; 2020 Dec; 11(6):1333-1349. PubMed ID: 33457005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of
    Alvarez CS; Ortiz J; Bendfeldt-Avila G; Xie Y; Wang M; Wu D; Higson H; Lee E; Teshome K; Barnoya J; Kleiner DE; Groopman JD; Orozco R; McGlynn KA; Gharzouzi E; Dean M
    Health Sci Rep; 2020 Jun; 3(2):e155. PubMed ID: 32382660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.
    Villar S; Le Roux-Goglin E; Gouas DA; Plymoth A; Ferro G; Boniol M; Lereau M; Bah E; Hall AJ; Wild CP; Mendy M; Norder H; van der Sande M; Whittle H; Friesen MD; Groopman JD; Hainaut P
    Environ Health Perspect; 2011 Nov; 119(11):1635-40. PubMed ID: 21768053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand.
    Galy O; Chemin I; Le Roux E; Villar S; Le Calvez-Kelm F; Lereau M; Gouas D; Vieco B; Suarez I; Navas MC; Chevallier M; Norder H; Srivatanakul P; Karalak A; Sangrajrang S; Trépo C; Hainaut P
    Hepat Res Treat; 2011; 2011():697162. PubMed ID: 21760996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus preS2Δ38-55 variants: A newly identified risk factor for hepatocellular carcinoma.
    Cohen D; Ghosh S; Shimakawa Y; Ramou N; Garcia PS; Dubois A; Guillot C; Kakwata-Nkor Deluce N; Tilloy V; Durand G; Voegele C; Ndow G; d'Alessandro U; Brochier-Armanet C; Alain S; Le Calvez-Kelm F; Hall J; Zoulim F; Mendy M; Thursz M; Lemoine M; Chemin I
    JHEP Rep; 2020 Oct; 2(5):100144. PubMed ID: 32904132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand.
    Ortiz-Cuaran S; Villar S; Gouas D; Ferro G; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    Cancer Lett; 2013 Apr; 331(1):46-51. PubMed ID: 23200676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy.
    Gouas D; Shi H; Hainaut P
    Cancer Lett; 2009 Dec; 286(1):29-37. PubMed ID: 19376640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.
    Gouas DA; Shi H; Hautefeuille AH; Ortiz-Cuaran SL; Legros PC; Szymanska KJ; Galy O; Egevad LA; Abedi-Ardekani B; Wiman KG; Hantz O; Caron de Fromentel C; Chemin IA; Hainaut PL
    Carcinogenesis; 2010 Aug; 31(8):1475-82. PubMed ID: 20538734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus genetic variation and TP53 R249S mutation in patients with hepatocellular carcinoma in Thailand.
    Thongbai C; Sa-nguanmoo P; Kranokpiruk P; Poovorawan K; Poovorawan Y; Tangkijvanich P
    Asian Pac J Cancer Prev; 2013; 14(6):3555-9. PubMed ID: 23886144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in Thailand: association with tumors developing in the absence of liver cirrhosis.
    Villar S; Ortiz-Cuaran S; Abedi-Ardekani B; Gouas D; Nogueira da Costa A; Plymoth A; Khuhaprema T; Kalalak A; Sangrajrang S; Friesen MD; Groopman JD; Hainaut P
    PLoS One; 2012; 7(6):e37707. PubMed ID: 22675488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.
    Navas MC; Suarez I; Carreño A; Uribe D; Rios WA; Cortes-Mancera F; Martel G; Vieco B; Lozano D; Jimenez C; Gouas D; Osorio G; Hoyos S; Restrepo JC; Correa G; Jaramillo S; Lopez R; Bravo LE; Arbelaez MP; Scoazec JY; Abedi-Ardekani B; Santella RM; Chemin I; Hainaut P
    Hepat Res Treat; 2011; 2011():582945. PubMed ID: 22114738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between exposure to aflatoxin, mutation in TP53, infection with hepatitis B virus, and occurrence of liver disease in a selected population in Hyderabad, India.
    Anitha S; Raghunadharao D; Waliyar F; Sudini H; Parveen M; Rao R; Kumar PL
    Mutat Res Genet Toxicol Environ Mutagen; 2014 May; 766():23-8. PubMed ID: 24657665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of aflatoxin induced p53 mutation at codon 249 (R249s) in hepatocellular carcinoma patients with and without hepatitis B surface antigen (HBsAg).
    Chittmittrapap S; Chieochansin T; Chaiteerakij R; Treeprasertsuk S; Klaikaew N; Tangkijvanich P; Komolmit P; Poovorawan Y
    Asian Pac J Cancer Prev; 2013; 14(12):7675-9. PubMed ID: 24460352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
    Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
    Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First Molecular Characterization of Chronic Hepatitis B Carriers in Timbuktu, Mali.
    Lawrence P; Chabane M; Abrouk L; Thiesson A; Berthé D; Diarra AB; Bengaly K; Traoré B; Kassogué D; Durand G; Voegele C; Le Calvez-Kelm F; Steenkeste N; Hainaut P; Kouriba B; Gormally E
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma.
    Marchio A; Amougou Atsama M; Béré A; Komas NP; Noah Noah D; Atangana PJA; Camengo-Police SM; Njouom R; Bekondi C; Pineau P
    Clin Exp Med; 2018 Aug; 18(3):421-431. PubMed ID: 29749584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enrichment in selected genotypes, basal core and precore mutations of hepatitis B virus in patients with hepatocellular carcinoma in Cameroon.
    Atsama Amougou M; Marchio A; Bivigou-Mboumba B; Noah Noah D; Banai R; Atangana PJA; Fewou Moundipa P; Pineau P; Njouom R
    J Viral Hepat; 2019 Sep; 26(9):1086-1093. PubMed ID: 31106515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.